HQH
EquityTekla Healthcare Investors
Financial Services · Asset Management
$19.15
+19.15 (+0.00%)
Open
N/A
Day Range
$19.02 - $19.34
52W Range
$13.77 - $20.46
Volume
116K
Price History
Key Statistics
Market Cap
N/A
P/E Ratio
N/A
EPS
N/A
Dividend Yield
N/A
P/B Ratio
N/A
Payout Ratio
N/A
ROE
N/A
Debt/Equity
N/A
Insider Activity
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 16, 2024 |
DIMARTINO ROSE Director |
Buy | 1,000 | $18.9K |
| Apr 9, 2024 |
GOETZ KATHLEEN Director |
Buy | 525 | $8.6K |
Institutional Ownership
| Holder | Shares | % Held | Value |
|---|---|---|---|
| Morgan Stanley | 4,683,466 | 8.70% | $89.9M |
| Penserra Capital Management LLC | 1,321,145 | 2.45% | $25.4M |
| Raymond James Financial, Inc. | 1,182,931 | 2.20% | $22.7M |
| Royal Bank of Canada | 517,085 | 0.96% | $9.9M |
| LPL Financial LLC | 501,067 | 0.93% | $9.6M |
| Advisors Asset Management, Inc. | 463,367 | 0.86% | $8.9M |
| Ameriprise Financial, Inc. | 456,049 | 0.85% | $8.8M |
| Needham Investment Management, L.L.C. | 291,930 | 0.54% | $5.6M |
| WNY Asset Management, LLC | 213,950 | 0.40% | $4.1M |
| Janney Montgomery Scott LLC | 189,898 | 0.35% | $3.6M |
Latest News
Fair Value Estimate
DDM Value
$174.10
Growth: 8.6% | Req. return: 10%
Peers in Financial Services
| Symbol | Name | Price | Mkt Cap | Div Yield | Change |
|---|---|---|---|---|---|
| AJG | Arthur J. Gallagher & Co. | $228.24 | N/A | 1.14% | +0.00% |
| AERIL.XC | Aquila European Renewables PLC | $0.23 | N/A | 38.74% | +0.00% |
| CS.PA | AXA | $41.46 | N/A | 5.19% | +0.00% |
| AXP | American Express Company | $308.78 | N/A | 1.06% | +0.00% |
| BRK-B | Berkshire Hathaway Inc. New | $505.23 | N/A | - | +0.00% |
| BK | The Bank of New York Mellon Cor | $119.07 | N/A | 1.73% | +0.00% |
| BG.VI | BAWAG Group AG | $132.00 | N/A | 4.17% | +0.00% |
| AB | AllianceBernstein Holding L.P. | $39.30 | N/A | 8.60% | +0.00% |
About Tekla Healthcare Investors
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Dividend Safety
Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.
Borderline
Based on 4 fundamental factors
Analysis Tools
Share
Dividend History
Dividend Safety
Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.
Borderline
Based on 4 fundamental factors
Dividend Growth
1Y CAGR
-3.9%
3Y CAGR
+8.6%
5Y CAGR
N/A
10Y CAGR
N/A
5-Year Dividend Projection
| Year | Conservative | Base | Optimistic |
|---|
Based on historical CAGR. Not a guarantee of future dividends.
View Full Projection →Loading financial data...
Revenue & Earnings
No financial statement data available for HQH.